[Polypharmacy is of major concern in cardiology]

Wien Med Wochenschr. 2010 Jun;160(11-12):264-269. doi: 10.1007/s10354-010-0784-3.
[Article in German]

Abstract

Quality improvement in cardiology over the past decade focused on management of acute coronary syndrome with invasive and innovative medical therapies, optimizing treatment of congestive heart failure and the development of repair procedures in valvular heart disease. On the other hand cardiologist and the attendant physicians are confronted with changes in the characteristics of patients in the light of demographic facts. Comorbidity and polypharmacy raise the need for clear concepts. Therapeutic and diagnostic tools of geriatric medicine may help in that context.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bradycardia / chemically induced*
  • Cardiovascular Agents / adverse effects*
  • Cardiovascular Agents / therapeutic use*
  • Drug Interactions
  • Drug Therapy, Combination
  • Frail Elderly
  • Heart Diseases / drug therapy*
  • Humans
  • Long QT Syndrome / chemically induced*
  • Prescription Drugs / adverse effects*
  • Prescription Drugs / therapeutic use*
  • Syncope / chemically induced*
  • Tachycardia / chemically induced*

Substances

  • Cardiovascular Agents
  • Prescription Drugs